EQT Just Rallied 8% on a Headline Miss
The market ignored the numbers and bought the strategy instead.
The market ignored the numbers and bought the strategy instead.
Defense demand is undeniable. The margin story is what needs answering now.
Coca-Cola's bull case is intact, but two major wildcards are about to get priced in.
A rare disease dealmaker just bought its way into a new disease category with $5B in peak revenue potential.
IBM's warning about enterprise cyber distraction just handed PANW its clearest catalyst yet.
Record profit, a $265B US bet, and a market asking the wrong question.
A Chapter 11 exit, a GE Aerospace deal, and an AI data center bet that Wall Street is still debating.
Q2 volume is already known. What happens to margins is the only question left.
Goldman’s Q2 beat was historic. The options market hadn’t fully priced it.
Vertiv ended 2025 with a $15.0B order backlog and is widely expected to report Q2 earnings on July 29. Put…